Commure's latest acquisition sends follow-up texts to patients
General Catalyst-backed Commure is buying another General Catalyst-backed startup that sends follow-up texts to patients.
Commure, which was valued at over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
